These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Propranolol blocks the tachycardia induced by galanin (1-15) but not by galanin (1-29). Díaz-Cabiale Z; Cordón MP; Coveñas R; Rivera A; Yanaihara N; Fuxe K; González-Barón S; Narváez JA Regul Pept; 2002 Jul; 107(1-3):29-36. PubMed ID: 12137963 [TBL] [Abstract][Full Text] [Related]
6. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855 [TBL] [Abstract][Full Text] [Related]
7. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11287-91. PubMed ID: 7504301 [TBL] [Abstract][Full Text] [Related]
8. Intracisternal galanin/angiotensin II interactions in central cardiovascular control. Díaz-Cabiale Z; Parrado C; Vela C; Coveñas R; Yanaihara N; Fuxe K; González-Barón S; Narváez JA Regul Pept; 2005 Apr; 127(1-3):133-40. PubMed ID: 15680479 [TBL] [Abstract][Full Text] [Related]
9. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype. Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563 [TBL] [Abstract][Full Text] [Related]
10. New high affinity peptide antagonists to the spinal galanin receptor. Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348 [TBL] [Abstract][Full Text] [Related]
12. Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure. Chen A; Li M; Song L; Zhang Y; Luo Z; Zhang W; Chen Y; He B Cardiovasc Ther; 2015 Oct; 33(5):288-93. PubMed ID: 26177027 [TBL] [Abstract][Full Text] [Related]
13. Role of galanin and galanin(1-15) on central cardiovascular control. Díaz-Cabiale Z; Parrado C; Vela C; Razani H; Coveñas R; Fuxe K; Narváez JA Neuropeptides; 2005 Jun; 39(3):185-90. PubMed ID: 15944010 [TBL] [Abstract][Full Text] [Related]
14. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. McDonald MP; Willard LB; Wenk GL; Crawley JN J Neurosci; 1998 Jul; 18(13):5078-85. PubMed ID: 9634573 [TBL] [Abstract][Full Text] [Related]
15. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin. McDonald MP; Wenk GL; Crawley JN Behav Neurosci; 1997 Jun; 111(3):552-63. PubMed ID: 9189270 [TBL] [Abstract][Full Text] [Related]
16. Feeding induced by pharmacological blockade of fatty acid metabolism is selectively attenuated by hindbrain injections of the galanin receptor antagonist, M40. Koegler FH; Ritter S Obes Res; 1996 Jul; 4(4):329-36. PubMed ID: 8822757 [TBL] [Abstract][Full Text] [Related]
18. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Leibowitz SF; Kim T Brain Res; 1992 Dec; 599(1):148-52. PubMed ID: 1283559 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Cellier E; Barbot L; Regoli D; Couture R Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960 [TBL] [Abstract][Full Text] [Related]